JPTCP is official journal of below Associations.
The Canadian Association for Population Therapeutics (CAPT) is a national organization of scientists and researchers from academic, government, industry and consulting backgrounds. Research spans and reflects our diverse base and includes epidemiology, economics and policy decision-making across a number of disease strands and unique stakeholder interests.
History of CAPTstrong>
CAPT had its origins in the early 1990's when members of the pharmacoepidemiology community in Canada came together to organize annual conferences on pharmacoepidemiology. The first Canadian Pharmacoepidemiology Forum was held in Toronto in 1993.
The creation of the Canadian Association for Population Therapeutics was declared at the September 1995 meeting of the International Society for Pharmacoepidemiology (ISPE). This was followed by a further announcement at the annual Canadian Pharmacoepidemiology Forum in 1996, and the first general election of the CAPT Board of Directors in 1996/97. While pharmacoepidemiology was initial focus of the membership, the founders did not want to limit the scope of the association's potential future activities and opted for an association name which would allow for growth into other related disciplines such as pharmacoeconomics as well as the study of other therapeutic interventions.
True to this vision, the organization has evolved into a dynamic group of like-minded researchers, conducting both epidemiology and economic analyses, who are located in academic, government, consulting and industry arenas. As the voice of population therapeutics in Canada, CAPT is the only national association of its kind committed to fostering ongoing networking between practitioners, researchers and policy makers, and increasing the visibility and recognition of the organization and its members.
A Little Bit of Historystrong>
CSPT is the official Canadian member of the International Union of Basic & Clinical Pharmacology (IUPHAR). James Hammond and Rommel Tirona are the Canadian IUPHAR delgates.
CSPT is a Canadian not-for-profit charitable organization with a VISION to be the national voice fostering the application of educational and research excellence to drug discovery and therapeutic choice.
The society’s MISSION is to bring together a multidisciplinary group with broad interest in optimally safe and effective drug therapy.
The values of CSPT include:
The Canadian Society of Pharmacology and Therapeutics (CSPT) became an entity on July 1, 2008 after the merger of the Canadian Society for Clinical Pharmacology (CSCP) and the Pharmacological Society of Canada (PSC) into one society. Both CSCP and PSC had been in existence for over 25 years. The CSPT is a non-profit organization devoted to the promotion of research and education in pharmacology and therapeutics. Members of the Society include students, postdoctoral fellows, established researchers and clinician scientists from academia, as well as individuals interested in pharmacology and therapeutics from government and industry. Combining basic and clinical pharmacology under one umbrella will facilitate better knowledge translation from bench to bedside resulting in better outcomes for patients using therapeutics.
The FACE Research Network and Roundtablestrong>
FACE (Fetal Alcohol Canadian Expertise) is a network of nearly 200 researchers, program providers and other stakeholders, actively engaged in FASD prevention and intervention. At FACE Research Roundtables held each year on or about September 9th, members and guests continue the time-honored tradition of research collaboration -- presenting scientific findings for peer review, describing successful service models, and identifying next steps in the fight against FASD. Since 2000, Roundtable participants have been the first to: uncover new findings on alcohol's effects on the brain; determine the incidence of FASD in various regions and populations; quantify the direct medical and educational costs of FASD in Canada and social impact of FASD on an individual's life; develop new screening methods; highlight the role of fathers in the prevention of FASD; identify the service needs of children affected by FASD and develop award-winning programs to help pregnant women who use alcohol overcome their addiction.